A new inclusion complex of amlodipine besylate and soluble β-cyclodextrin polymer: Preparation, characterization and dissolution profile

Journal of Inclusion Phenomena and Macrocyclic Chemistry

Volumn 76, Issue 1-2, 2013, Pages 19-28

  Lauro, M R ^a   Carbone, C ^b   Auditore, R ^b   Musumeci, T ^b   Santagati, N A ^b   Aquino, R P ^a   Puglisi, G ^b  

^a UNIVERSITY OF SALERNO   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

Author keywords

Amlodipine besylate; In vitro dissolution release test; Inclusion complex; Morphological and physicochemical characterization; Phase solubility; Soluble cyclodextrin polymer

Indexed keywords

EID: 84877583925     PISSN: 09230750     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10847-012-0168-y     Document Type: Article

References (34)

1. Brooks W.C.: Veterinary Partner. http://www.veterinarypartner.com/ Content.plx?P=A&C=31&A=1215&S=0 (2009). Accessed 1 Nov 2011
2. Clavijo, G.A., de Clavijo, I.V., Weart, C.W.: Amlodipine: a new calcium antagonist. Am. J. Hosp. Pharm. 51(1), 59-68 (1994)
3. Murdoch, D., Heel, R.C.: Amlodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiovascular disease. Drugs 41(3), 478-505 (1991)
4. Cooke, K.L., Snyder, P.S.: Calcium channel blockers in veterinary medicine. J. Vet. Intern. Med. 12(3), 123-131 (1998)
5. Fasani, E., Albini, A., Gemme, S.: Mechanism of the photochemical degradation of amlodipine. Int. J. Pharm. 352(1-2), 197-201 (2008)
6. Brewster, M.E., Loftsson, T.: Cyclodextrins as pharmaceutical solubilizers. Adv. Drug Deliv. Rev. 59, 645-666 (2007)
7. Nikolić, V., Nikolić, L., Stanković, M., Cakić, M., Stanojević, L., Ilić, D.: Inclusion complexes of amlodipine besylate and cyclodextrins. Cent. Eur. J. Chem. 8(4), 834-841 (2010)
8. Mielcarek, J., Czernielewska, A., Czarczyńska, B.: Inclusion complexes of felodipine and amlodipine with methyl-β-cyclodextrin. J. Incl. Phenom. Macrocycl. Chem. 54(1-2), 17-21 (2006)
9. Ling, W., Xuehua, J., Weijuan, X., Chenrui, L.: Complexation of tanshinone IIA with 2-hydroxypropyl-b-cyclodextrin: effect on aqueous solubility, dissolution rate, and intestinal absorption behavior in rats. Int. J. Pharm. 341, 58-67 (2007)
10. Puglisi, G., Santagati, N.A., Ventura, C.A., Pignatello, R., Panico, A.M., Spampinato, S.: Enhancement of 4-biphenylacetic acid bioavailability in rats by its β-cyclodextrin complex after oral administration. J. Pharm. Pharmacol. 43, 430-432 (1991)
11. Puglisi, G., Ventura, C.A., Spadaro, A., Campana, G., Spampinato, S.: Differential effects of modified β-cyclodextrins on pharmacological activity and bioavailability of 4-biphenylacetic acid in rats after oral administration. J. Pharm. Pharmacol. 47, 120-123 (1995)
12. Ventura, C.A., Fresta, M., Giovinazzo, C., Puglisi,' G.: Solid state characterization and in solution studies of idebenone-β-cyclodextrin inclusion complex. Acta Tecnol. Legis Medicam. VI, 56-66, N.1 (1995)
13. Ventura, C.A., Fresta, M., Vandelli, M.A., Cavallaro, G., Zappalà, M.T., Puglisi, G.: Preparation and physico-chemical study of inclusion complexes between idebenone and β-cyclodextrin. J. Incl. Phenom. Mol. Recognit. Chem. 24, 193-210 (1996)
14. Ventura, C.A., Giannone, I., Paolino, D., Pistarà, V., Corsaro, A., Puglisi, G.: Preparation of celecoxib-dimethyl-β-cyclodextrin inclusion complex: characterization and in vitro permeation study. Eur. J. Med. Chem. 40, 624-631 (2005)
15. Amididouche, D., Darrouzet, H., Duchene, D., Poelman, M.C.: Inclusion of retinoic acid. J. Pharm. Sci. Technol. 2(3), 171-183 (2010)
16. Duchene, D., Vaution, C., Glomot, F.: Amelioration de la dissolution et de la biodisponibilitè des principles actifs par inclusion dans ls cyclodextrines. STP Pharma. 1, 323-332 (1985)
17. Somagoni, J.M., Dharani, S., Panakanti, P.K., Koorelli, S., Manda, S., Madhusudan, R.Y.: Stereospecific dissolution of inclusion complexes of amlodipine base and its besylate enantiomers with hydroxypropyl-β- cyclodextrin. Lat. Am. J. Pharm. 30(7), 1309-1316 (2011)
18. Somagoni, J., Reddy, S., Katakam, V.K., Koorelli, S., Manda, S., et al.: Preparation of inclusion complexes of amlodipine base and its besylate and maleate salts with hydroxy propyl β-cyclodextrin - a study on stereospecific dissolution. Pharm. Anal. Acta 2, 123 (2011). doi: 10.4172/2153-2435.1000123v
19. Vélaz, I., Isasi, J.R., Sánchez, M., Uzqueda, M., Ponchel, G.: Structural characteristics of some soluble and insoluble β-cyclodextrin polymers. J. Incl. Phenom. Macrocycl. Chem. 57(1-4), 65-68 (2007)
20. Loftsson, T., Brewster, M.E.: Pharmaceutical applications of cyclodextrins 1 drug solubilization and stabilization. J. Pharm. Sci. 85(10), 1017-1025 (1996)
21. Nianbing, L., Jianping, D., Hongqing, C., Guonan, C.: Determination of the binding constant for the inclusion complex between procaine hydrochloride and b-cyclodextrin by capillary electrophoresis. Talanta 59, 493-499 (2003)
22. Benesi, H.A., Hildebrand, J.H.: A spectrophotometric investigation of the interaction of iodine with aromatic hydrocarbons. J. Am. Chem. Soc. 71, 2703-2707 (1949)
23. Guo, Q.X., Liu, H.Y., Ruan, X.Q., Zheng, X.Q., Shi, Y.Y., Liu, Y.C.: Experimental and theoretical studies on the inclusion complexation of β-cyclodextrin with phenothiazine derivatives. J. Incl. Phenom. Macrocycl. Chem. 35, 487-496 (1999)
24. Göktürk, S., ÇalIskan, E., Talman, R.Y., Var Marmara, U.: A study on solubilization of poorly soluble drugs by cyclodextrins and micelles: complexation and binding characteristics of sulfamethoxazole and trimethoprim. http://www.tswj.com/aip/718791.pdf. Accessed 12 March 2012
25. Higuchi, T., Connors, K.A.: Phase-solubility techniques. Adv. Anal. Chem. Instrum. 4, 117-212 (1965)
26. Chadna, R., Kashid, N., Saini, A.: Account of analytical employed techniques for the determination of thermodynamics of inclusion complexation of drugs with cyclodextrins. J. Sci. Ind. Res. 63, 211-229 (2004)
27. Spulber, M., Pinteala, M., Harabagiu, V., Simionescu, B.C., Fifere, A.: Spectroscopic characterization of α-cyclodextrin-sulconazole inclusion complexes. Determination of binding constants by Rose-Drago approximation. Rom. Soc. Med. Mycol. Mycotoxicol. 2(2), 189-192 (2008)
28. Loftsson, T., Hreinsdottir, D., Masson, M.: Evaluation of cyclodextrin solubilization of drugs. Int. J. Pharm. 302, 18-28 (2005)
29. Fernandes, C., Viera, M.T., Veiga, F.: Physicochemical chraracterization and in vitro dissolution behavior of nicardipine-cyclodextrins inclusion compounds. Eur. J. Pharm. Sci. 15, 79-88 (2002)
30. Ammar, H.O., Salama, H.A., Ghorab, M., Mahmoud, A.A.: Inclusion complexation of glimepiride in dimethyl-β-cyclodextrin. Asian J. Pharm. Sci. 2(2), 44-55 (2007)
31. Cupka, P., Bella, J., Martvon, A.: Synthesis and spectral properties of substituted 1,4 dihydropiridines and 1,4,5,6,7,8-hexahydroquinolines. Collect. Czechoslov. Chem. Commun. 52, 742-775 (1987)
32. Jadhav, G.S., Vavia, P.R., Nandedkar, D.T.: Danazol-β-cyclodextrin binary system: a potential application in emergency contraception by the oral route. AAPS PharmSciTech. 8(2), Article 35 (2007). doi: 10.1208/pt0802035
33. Xiang, T.X., Andersoon, B.D.: Inclusion complexes of purine nucleosides with cyclodextrins: II. Investigation of inclusion complex geometry and cavity microenvironment. Int. J. Pharm. 59(1), 45-55 (1990)
34. Marini, A., Berbenni, V., Bruni, G., Mustarelli, P., Giordano, F., Villa, M.: Thermoanalytical and spectroscopic characterization of betacyclodextrin/ ketoprofen inclusion complexes. J. Incl. Phenom. Mol. Recognit. Chem. 22, 221-234 (1995)